SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models
Maysoun Shomali(Sanofi (United States)), Monsif Bouaboula(Sanofi (United States))
Cited by 67